Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Beyond Quality: PAT as a Catalyst for Carbon Reduction in Pharma
Trends in Single-Use Mixing Technologies and Insight into Pall and Lonza Ibex® Solutions
Cleanability and Re-Usability of Cadence™ Inline Diafiltration Modules
Accelerating the Commercialization of Biosimilar Medicines in India
Sartorius Stedim Biotech
View All Featured ArticlesHeadline News
Roche receives CE Mark for compact cobas smart e immunoanalyser
Roche launches VENTANA BAP1 test to support mesothelioma diagnosis
Intranasal foralumab reduces microglial activation in Phase IIa progressive MS trial
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Handling mutagenic extractable and leachable compounds released from devices
Presented by Ron Brown, Toxicologist at Risk Science Consortium and Piet Christieans, PhD, Scientific Director at Nelson Labs
10th February 2022
Advances and Challenges in Vaccine Development and Manufacture
Presented by Tony D'Amore, Vice Preseident, Product Research & Development at Sanofi Pasteur
02nd November 2018
End User Perspective on Setting in-Process Endotoxin Limits
Presented by Dr Friedrich von Wintzingerode, Roche/Genentech
15th May 2018
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Amsphere TM A3
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
